{"id":"terlipressin-injectable-product","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2135460","moleculeType":"Protein","molecularWeight":"1227.40"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by stimulating V2 receptors in the kidneys, leading to water reabsorption and increased blood pressure. This effect is particularly useful in treating certain types of shock and bleeding disorders.","oneSentence":"Terlipressin is a synthetic analogue of vasopressin that acts as a potent vasoconstrictor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:03.128Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemorrhagic shock"},{"name":"Hepatorenal syndrome"}]},"trialDetails":[{"nctId":"NCT06815770","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal Bleed","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-02-10","conditions":"Acute on Chronic Liver Failure","enrollment":60},{"nctId":"NCT06122792","phase":"NA","title":"Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2024-01","conditions":"Portal Hypertension, Gastric Varices Bleeding, Portosystemic Shunt","enrollment":144},{"nctId":"NCT05207280","phase":"PHASE3","title":"Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic Shock","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-10-11","conditions":"Septic Shock","enrollment":152},{"nctId":"NCT05806307","phase":"PHASE4","title":"Methods Decreasing Bleeding in Open Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03-15","conditions":"Misoprostol Allergy, Oxytocin Allergy, Tranexamic Acid Allergy","enrollment":105},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":"Neonatal Sepsis, Refractory Shock","enrollment":36},{"nctId":"NCT04028505","phase":"PHASE3","title":"Terlipressin Infusion in Variceal Hemorrhage","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2018-10-25","conditions":"Terlipressin Adverse Reaction","enrollment":128},{"nctId":"NCT01921985","phase":"PHASE2","title":"Terlipressin Administration in Patients Undergoing Major Liver Resection","status":"TERMINATED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2013-11","conditions":"Liver Resection, Liver Failure","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Novapressin"],"phase":"phase_3","status":"active","brandName":"Terlipressin Injectable Product","genericName":"Terlipressin Injectable Product","companyName":"Aga Khan University","companyId":"aga-khan-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Terlipressin is a synthetic analogue of vasopressin that acts as a potent vasoconstrictor. Used for Hemorrhagic shock, Hepatorenal syndrome.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}